@article{ref1,
title="Brand and generics companies unite to pressure FDA: they want the agency to drop its safety-label plan and adopt their alternative",
journal="Pharmacy and therapeutics",
year="2015",
author="Barlas, Stephen",
volume="40",
number="8",
pages="501-503",
abstract="Fear of lawsuits and customer confusion have greeted a U.S. Food and Drug Administration plan to let generic drug companies change labels quickly, without prior agency approval, when they learn of adverse effects once the generic reaches the market.<p /> <p>Language: en</p>",
language="en",
issn="1052-1372",
doi="",
url="http://dx.doi.org/"
}